Insights on the immunogenicity of antibody–drug conjugates

Emerging formats for next-generation antibody drug conjugates

(2015) Mahendra P Deonarain et al.   Expert Opinion on Drug Discovery

Immunogenicity of Antibody Drug Conjugates: Bioanalytical Methods and Monitoring Strategy for a Novel Therapeutic Modality

(2014) M. Benjamin Hock et al.   AAPS Journal

Recommendations for the characterization of immunogenicity response to multiple domain biotherapeutics

(2014) Boris Gorovits et al.   JOURNAL OF IMMUNOLOGICAL METHODS

The Next Generation of Antibody Drug Conjugates

(2014) Fiona Mack et al.   SEMINARS IN ONCOLOGY

Site-specific antibody drug conjugates for cancer therapy

(2013) Siler Panowski et al.   mAbs

Immunogenicity assays for antibody–drug conjugates: case study with ado-trastuzumab emtansine

(2013) Montserrat Carrasco-Triguero et al.   Bioanalysis

Immunogenicity testing strategy and bioanalytical assays for antibody–drug conjugates

(2013) Sarah A Hoofring et al.   Bioanalysis

Targeting the Hemoglobin Scavenger receptor CD163 in Macrophages Highly Increases the Anti-inflammatory Potency of Dexamethasone

(2012) Jonas H Graversen et al.   MOLECULAR THERAPY

Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates

(2012) Ben-Quan Shen et al.   NATURE BIOTECHNOLOGY

Overcoming soluble target interference in an anti-therapeutic antibody screening assay for an antibody–drug conjugate therapeutic

(2012) Montserrat Carrasco-Triguero et al.   Bioanalysis

Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products

(2008) Eugen Koren et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products

(2008) Gopi Shankar et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS